Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank85
3Y CAGR-5.4%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-5.4%/yr
Quarterly compound
Percentile
P85
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 33.47% |
| Q3 2025 | 38.13% |
| Q2 2025 | 19.03% |
| Q1 2025 | -8.68% |
| Q4 2024 | 1.31% |
| Q3 2024 | 29.65% |
| Q2 2024 | 6.83% |
| Q1 2024 | 14.73% |
| Q4 2023 | -7.03% |
| Q3 2023 | -24.58% |
| Q2 2023 | -34.18% |
| Q1 2023 | -72.21% |
| Q4 2022 | 39.59% |
| Q3 2022 | -291.97% |
| Q2 2022 | 71.62% |
| Q1 2022 | -36.27% |
| Q4 2021 | 5.39% |
| Q3 2021 | -349.20% |
| Q2 2021 | -38.76% |
| Q1 2021 | 189.70% |
| Q4 2020 | -13.11% |
| Q3 2020 | -211.94% |
| Q2 2020 | -66.07% |
| Q1 2020 | -38.60% |
| Q4 2019 | -107.34% |
| Q3 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |